As Director of CDER’s Office of Regulatory Policy (ORP), Elizabeth Jungman, J.D., M.P.H., helps oversee the development and implementation of regulations, policies, and procedures that affect nearly every aspect of the Center for Drug Evaluation and Research (CDER). She advises senior FDA officials on matters impacting policy development and long-range organizational goals.
Ms. Jungman is a nationally recognized expert in drug regulatory policy. Before joining CDER, she was the Director of Public Health Programs at the Pew Charitable Trusts. She has also served as Senior Health Policy Adviser with the U.S. Senate Committee on Health, Education, Labor, and Pensions, where she played a crucial role in drafting and negotiating the Food and Drug Administration Safety and Innovation Act of 2012 and other health- and drug-related legislation, including, pandemic preparedness, drug compounding, and supply chain security.
Ms. Jungman earned her bachelor’s degree in biology from Harvard College, law degree from Georgetown University, and a master’s degree in public health from Johns Hopkins.